Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 3,450 | 0 | 0 | 0 | 0 |
| Cost of Goods | 3,300 | 0 | 0 | 0 | 0 |
| Gross Profit | 150 | 0 | 0 | 0 | 0 |
| Operating Expenses | 17,220 | 14,270 | 17,730 | 15,120 | 7,000 |
| Operating Income | -16,770 | -14,270 | -17,730 | -15,120 | -7,000 |
| Other Income | 350 | -10 | 590 | 2,450 | 1,510 |
| Pre-tax Income | -16,420 | -14,280 | -17,140 | -12,670 | -5,490 |
| Income Tax | 40 | 0 | 0 | 0 | 0 |
| Net Income Continuous | 16,473 | -14,288 | -17,140 | -12,670 | -5,490 |
| Net Income | $-16,470 | $-14,280 | $-17,140 | $-12,670 | $-5,490 |
| EPS Basic Total Ops | 6.00 | -6.50 | -7.50 | N/A | N/A |
| EPS Basic Continuous Ops | 6.11 | -6.39 | -7.71 | N/A | N/A |
| EPS Diluted Total Ops | 6.00 | -6.50 | -7.50 | N/A | N/A |
| EPS Diluted Continuous Ops | 6.11 | -6.39 | -7.71 | N/A | N/A |
| EBITDA(a) | $-16,460 | $-13,830 | $-17,260 | $-14,750 | $-6,710 |